Is 'Gym Penis' Real? Retatrutide Access Expanded; Vitamin D Fails Cancer Test
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Is 'Gym Penis' Real? Retatrutide Access Expanded; Vitamin D Fails Cancer Test" is generating significant coverage in the Health category, with 4 articles from 4 distinct sources tracked by PULSE so far.
Outlets currently covering the story include PinkNews, eurweb.com, attitude.co.uk and MedPage Today. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 91d ago.
Quick answers
Why is "Is 'Gym Penis' Real? Retatrutide Access Expanded; Vitamin D Fails Cancer Test" trending?
Because 4 independent news sources published 4 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (4)
- ‘Gym penis’ PinkNews · 100d ago
- What Is ‘Gym Penis’? Why Men May Notice Changes After a Workout eurweb.com · 100d ago
- ‘Gym penis’ is trending online attitude.co.uk · 100d ago
- Is 'Gym Penis' Real? Retatrutide Access Expanded; Vitamin D Fails Cancer Test MedPage Today · 100d ago
Topics
Related trends
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials
Eli Lilly's experimental triple-hormone drug retatrutide cut knee osteoarthritis pain and produced average weight loss of roughly 25% in two Phase 3 trials involving more than 1,000 adults with obesity.
What a new study reveals about reversing type 2 diabetes
A new study found that 54% of younger adults with early-onset type 2 diabetes achieved remission after six months of an intensive diet and exercise program.
Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss
Eli Lilly reports that its new drug, retatrutide, achieved more than double the weight loss of Ozempic's highest approved dose in a head-to-head trial.
Retatrutide reduces knee pain and body weight in osteoarthritis patients - News-Medical
Experimental drug retatrutide cut knee osteoarthritis pain by half for nearly 70% of patients across two clinical trials while also reducing body weight.
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials
An experimental weight-loss drug significantly eased knee pain in two major new trials, according to coverage from Everyday Health.
When the Boss on the Phone Isn’t Real: How More Than $129 Million Was Stolen Using A.I.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.